Advertisement
Graham will be responsible for all Finance and Information Servicesmatters in North America, effective January 1, 2009. He will be a member ofthe US Leadership Team and will report to Rich Fante, President, AstraZenecaUS.
Advertisement
In announcing Baker's appointment, Fante said, "Graham brings a wealth ofexpertise and experience that will be central as we deliver continued businesssuccess and make a meaningful difference to patient health."
Graham has 18 years of finance experience, including 13 at AstraZeneca,most recently as Regional Finance Director, Asia Pacific, based in Singapore.In this role, he was accountable for Finance, Information Services andSourcing across the Asia Pacific Region and the delivery of sales, costs andprofits in this key growth region for the company. As a member of theregional management team, Graham was also closely involved with all majorinvestments across 13 countries, including significant expansions in China,India and Indonesia.
Before that, Graham held several finance leadership positions, includingCFO of AstraZeneca Japan, Business Development Director responsible forfinancial and commercial evaluations of key acquisitions, and Global MarketingFinance Director for the cardiovascular therapy area. Prior to joiningAstraZeneca, he qualified as a Chartered Accountant and Chartered Tax Advisorworking for Arthur Andersen. Graham holds an MA degree in Economics fromCambridge University in England.
About AstraZeneca
AstraZeneca is a major international healthcare business engaged in theresearch, development, manufacturing and marketing of meaningful prescriptionmedicines and supplier for healthcare services. AstraZeneca is one of theworld's leading pharmaceutical companies with healthcare sales of $29.55billion and is a leader in gastrointestinal, cardiovascular, neuroscience,respiratory, oncology and infectious disease medicines. In the United States,AstraZeneca is a $13.35 billion dollar healthcare business with 12,200employees committed to improving people's lives. AstraZeneca is listed in theDow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
For more information visit www.astrazeneca-us.com.
SOURCE AstraZeneca
